Everything tagged "financials" across research, earnings, and macro.
40 articles
Santander is delivering record profits, improving efficiency, and using Openbank to lower funding costs and expand returns. The stock looks like a Buy for investors who want a diversified global bank with solid capital and visible earnings momentum.
Synchrony Financial is posting strong profitability, improving credit trends, and aggressive capital returns while trading at a depressed earnings multiple. The report argues the stock still has room to rerate if execution remains steady.
The market is rotating away from the most crowded mega-cap growth trades, and this week’s tape makes that hard to deny. But the better read is selective rotation into banks and parts of industrials, not a blanket green light to chase every small-cap or cyclical laggard.
Regional banks look cheap enough to tempt value buyers, but cheap is not the same as cleared. The 2023 funding panic may be behind the group, yet the next phase of risk is CRE refinancing pressure that can keep earnings and multiples stuck for longer just as investors rotate back into financials.
If the Fed stays more hawkish than equity investors want to admit, financials look like a cleaner macro expression than hiding in pricey defensives or reflexively buying every tech dip. Banks and insurers are not a recession-proof all-clear, but in a sticky-rate regime they offer cheaper cash flows, less duration risk, and a better chance to outperform by simply being less crowded.
Jefferies just posted a very loud signal that the dealmaking rebound is real: investment-banking revenue surged 57% to a quarterly record. The stock got hit anyway, and that looks more like expectations getting reset after a huge run than the core franchise breaking.
Credicorp combines dominant Peru banking scale, strong profitability, and rising digital monetization. The stock looks attractive for medium-term investors, with Yape and low-cost funding supporting the growth case.
Prudential plc ADR combines solid Asia-led growth with strong capital generation and a shareholder-friendly buyback plan. The stock screens as a moderate-risk Buy with a valuation that still leaves room for upside.
Canadian Imperial Bank Of Commerce is delivering strong earnings momentum, improving profitability, and a healthier mix across retail, wealth, U.S. banking, and capital markets. The stock looks like a solid Buy, though valuation and credit risk keep it from being a screaming bargain.
Manulife combines a cash-generative insurance base with faster-growth exposure in Asia and Global WAM. FY2025 results, a 10% dividend hike, and a new buyback plan support a disciplined Buy case.
KBDC combines a conservative first-lien portfolio, solid dividend coverage, and strong liquidity, but softer earnings momentum limits upside. It looks best as an income-first Buy on weakness rather than a premium-growth story.
Lincoln National is emerging as a credible turnaround, with improving operating earnings across annuities, life, and group protection. The stock screens cheap, but negative free cash flow and market-sensitive results keep it in value-recovery territory.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the Generator